Kardigan, Inc.
Clinical trials sponsored by Kardigan, Inc., explained in plain language.
-
New drug trial aims to delay heart valve surgery
Disease control Recruiting nowThis study is testing whether an experimental drug called ataciguat can slow down the progression of moderate aortic valve stenosis, a condition where the heart's main valve narrows and stiffens. Researchers will enroll about 1,276 adults aged 50+ to receive either ataciguat or a…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug trial targets root cause of inherited heart failure
Disease control Recruiting nowThis study is testing an investigational drug called danicamtiv for people with a genetic form of dilated cardiomyopathy, a condition where the heart muscle is weak and enlarged. About 332 participants will take either danicamtiv or a placebo pill daily for six months to see if t…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC